00145-1/asset/5645eb6e-0d8f-4c7d-8739-b73d2b29730f/main.assets/gr2_lrg.jpg)
is tirzepatide good for menopause The role of hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study Postmenopausal women on the GLP-1
Description
Compare 116 GLP-1 weight loss doctors and clinics in New York, New York
For patients pursuing serious, sustained weight management who meet clinical criteria
The first cohort included 6696 patients who started GLP-1 receptor agonists and added on SGLT-2 inhibitors, and the second included 8942 patients who started SGLT-2 inhibitors and added on GLP-1 receptor agonists
Hypoglycaemia (particularly if used with insulin or sulfonylureas)
A new study found that adults with obesity significantly reduced their physical activity while taking GLP-1 medications for weight loss.
glp-1 glp-1
